Approval to commence Phase III trials of testosterone treatment

Rightly or wrongly, concerns over GM crops contaminating their non-GM kin have led to a stalemate in progress towards acceptance of GM crops and foods. We look at a new approach using gene silencing and gene imprinting.

Deciphering vertebrate development, sorting out the roosters from the hens and taking on bird flu - dare we say, all in one fowl swoop - that is the job of CSIRO's Dr Mark Tizard, who has created a new microRNA catalogue for the humble chook.

Strange beasts evolve on islands: flightless bats and birds, amphibious or monstrous lizards, huge tortoises, giant rodents, dwarf elephants and even humans, such as the famous 'hobbit', H. floresiensis.

It's been a big year for Starpharma, the Melbourne-based biotech working on a portfolio of applications for its dendrimer technology.

The genome of a newly emerging superbug, commonly known as Steno, reveals an organism with a remarkable capacity for drug resistance.

Salvador, Warts, Hippo and Yorkie are an eclectically named group of genes that form the core components of a signalling pathway in Drosophila that regulates control of organ size and may have some important parallels with human cancer.

Fossil bones of the Djarthia, our earliest known marsupial, have been linked to South America's extant Monito del Monte.

After becoming an epigenetics convert four years ago at Lorne and winning the Eppendorf Young Investigator's Award there two years ago, Dr Jeff Craig returns to Lorne in 2008 as an invited speaker to present the fruits of his conversion.

RNA microarray chip technology developed by the University of Queensland licensed to Invitrogen.

A tale of two melanocytes: why does one become a mole and the other a melanoma?